Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer

Go back to Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Cervical Cancer
Agilent Technologies Inc (NYSE: A) Delayed: 153.00 -6 (3.77%)
Previous Close $159.00    52 Week High $48.63 
Open $157.13    52 Week Low $34.15 
Day High $157.66    P/E 70.83 
Day Low $152.63    EPS $2.16 
Volume 1,312,735